Patents Assigned to Serpin Pharma, LLC
  • Peptides and methods of using the same
    Patent number: 11779630
    Abstract: Disclosed herein are SERPIN peptides, and analogues and derivatives thereof, and uses of the same for treating various conditions associated with LRP1 mediation.
    Type: Grant
    Filed: July 6, 2021
    Date of Patent: October 10, 2023
    Assignee: SERPIN PHARMA, LLC
    Inventors: Dana Austin, Cohava Gelber
  • METHODS FOR TREATMENT OF DISEASES
    Publication number: 20210369822
    Abstract: We describe peptides and their uses for the treatment of , e.g. acute myocardial infarction and other cytokine storm-associated conditions.
    Type: Application
    Filed: March 29, 2021
    Publication date: December 2, 2021
    Applicant: SERPIN PHARMA, LLC
    Inventor: Cohava GELBER
  • Peptides and methods of using same
    Patent number: 10899797
    Abstract: We describe peptides and their uses for the treatment of autoimmune, inflammatory and metabolic diseases.
    Type: Grant
    Filed: February 26, 2019
    Date of Patent: January 26, 2021
    Assignee: SERPIN PHARMA, LLC
    Inventors: Soren Mogelsvang, Cohava Gelber
  • METHODS FOR TREATMENT OF DISEASES
    Publication number: 20190328852
    Abstract: We describe peptides and their uses for the treatment of, e.g. acute myocardial infarction and other cytokine storm-associated conditions.
    Type: Application
    Filed: August 26, 2016
    Publication date: October 31, 2019
    Applicant: SERPIN PHARMA, LLC
    Inventor: Cohava GELBER
  • Peptides and methods of using same
    Patent number: 10214562
    Abstract: We describe peptides and their uses for the treatment of autoimmune, inflammatory and metabolic diseases.
    Type: Grant
    Filed: January 29, 2015
    Date of Patent: February 26, 2019
    Assignee: Serpin Pharma, LLC
    Inventors: Soren Mogelsvang, Cohava Gelber
  • Peptides and methods of using same
    Patent number: 9951104
    Abstract: We describe peptides and their uses for the treatment of autoimmune, inflammatory and metabolic diseases.
    Type: Grant
    Filed: January 7, 2013
    Date of Patent: April 24, 2018
    Assignee: Serpin Pharma, LLC
    Inventors: Soren Mogelsvang, Cohava Gelber
  • Peptides and methods of using same
    Patent number: 8975224
    Abstract: We describe peptides and their uses for the treatment of autoimmune, inflammatory and metabolic diseases.
    Type: Grant
    Filed: June 24, 2013
    Date of Patent: March 10, 2015
    Assignee: Serpin Pharma, LLC
    Inventors: Soren Mogelsvang, Cohava Gelber